Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Olena Madden, Jessica Walshe, Prem Kishore Patnala, John Barron, Claire Meaney & Patrick Murray. (2023) Phytocannabinoids - An Overview of the Analytical Methodologies for Detection and Quantification of Therapeutically and Recreationally Relevant Cannabis Compounds. Critical Reviews in Analytical Chemistry 53:1, pages 211-231.
Read now
Read now
Giulio Perugi, Alessandro Pallucchini, Salvatore Rizzato, Pietro De Rossi, Gabriele Sani, Angelo GI Maremmani, Vito Pinzone & Icro Maremmani. (2019) Pharmacotherapeutic strategies for the treatment of attention-deficit hyperactivity (ADHD) disorder with comorbid substance-use disorder (SUD). Expert Opinion on Pharmacotherapy 20:3, pages 343-355.
Read now
Read now
Philippe Lucas, Amanda Reiman, Mitch Earleywine, Stephanie K. McGowan, Megan Oleson, Michael P. Coward & Brian Thomas. (2013) Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients. Addiction Research & Theory 21:5, pages 435-442.
Read now
Read now
Philippe Lucas. (2012) Cannabis as an Adjunct to or Substitute for Opiates in the Treatment of Chronic Pain. Journal of Psychoactive Drugs 44:2, pages 125-133.
Read now
Read now
Jan A. Lindsay, Angela L. Stotts, Charles E. Green, David V. Herin & Joy M. Schmitz. (2009) Cocaine Dependence and Concurrent Marijuana Use: A Comparison of Clinical Characteristics. The American Journal of Drug and Alcohol Abuse 35:3, pages 193-198.
Read now
Read now
Articles from other publishers (28)
Anees BahjiDavid CrockfordJennifer BraschChristian SchutzLeslie Buckley, Marlon Danilewitz, Simon Dubreucq, Michael Mak & Tony P. George. (2024) Training in Substance use Disorders, Part 1: Overview of Clinical Practice Recommendations. The Canadian Journal of Psychiatry.
Crossref
Crossref
Florriann Fehr, Lindsay A. Lo, Chris Nelson, Kate Nanson, Lauren Diehl, Karl Nielson, Hudson Reddon & Zach Walsh. (2023) Stigma‐related barriers to medical cannabis as harm reduction for substance use disorder: Obstacles and opportunities for improvement. International Journal of Mental Health Nursing 33:1, pages 195-201.
Crossref
Crossref
Kim Boesen, Asger Sand Paludan-Müller, Peter C Gøtzsche & Karsten Juhl Jørgensen. (2022) Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database of Systematic Reviews 2022:2.
Crossref
Crossref
Holly Mansell, Declan Quinn, Lauren E Kelly, Michael Szafron & Jane Alcorn. (2021) Pharmacokinetics and Perceptions of Children and Young Adults Using Cannabis for Attention-Deficit/Hyperactivity Disorder and Oppositional Defiant Disorder: Protocol for a Mixed Methods Proof-of-Concept Study. JMIR Research Protocols 10:10, pages e31281.
Crossref
Crossref
Alessandro Pallucchini, Marco Carli, Angelo Maremmani, Marco Scarselli, Giulio Perugi & Icro Maremmani. (2021) Influence of Substance Use Disorder on Treatment Retention of Adult-Attention-Deficit/Hyperactive Disorder Patients. A 5-Year Follow-Up Study. Journal of Clinical Medicine 10:9, pages 1984.
Crossref
Crossref
Dimy Fluyau, Neelambika Revadigar & Christopher G. Pierre. (2020) Systematic Review and Meta‐Analysis: Treatment of Substance Use Disorder in Attention Deficit Hyperactivity Disorder. The American Journal on Addictions 30:2, pages 110-121.
Crossref
Crossref
Jennifer L. Bryan, Julianna Hogan, Jan A. Lindsay & Anthony H. Ecker. (2021) Cannabis use disorder and post-traumatic stress disorder: The prevalence of comorbidity in veterans of recent conflicts. Journal of Substance Abuse Treatment 122, pages 108254.
Crossref
Crossref
Marina Roizenblatt, Thiago Marques Fidalgo, Murilo Polizelli, Natasha Ferreira Santos da Cruz, Arnaldo Roizenblatt, Kim Jiramongkolchai, Peter Louis Gehlbach, Michel Eid Farah, Rubens BelfortJr.Jr. & Mauricio Maia. (2021) Effect of chronic cocaine use on fine motor coordination tested during ophthalmic vitreoretinal simulated performance. Journal of Psychiatric Research 132, pages 7-12.
Crossref
Crossref
Thiago Wendt Viola, Breno Sanvicente-Vieira, Bruno Kluwe-Schiavon, Leonardo Melo Rothmann, João Vítor Nóbrega e Mélo-Pereira, Carla Bicca, João Paulo Ottolia Niederauer, Joy Schmitz & Rodrigo Grassi-Oliveira. (2020) Association Between Recent Cannabis Consumption and Withdrawal-Related Symptoms During Early Abstinence Among Females With Smoked Cocaine Use Disorder. Journal of Addiction Medicine 14:4, pages e37-e43.
Crossref
Crossref
Arun Garimella, Sourabh Rajguru, Umesh Kumar Singla & Vinoo Alluri. (2020) Marijuana and the hippocampus: A longitudinal study on the effects of marijuana on hippocampal subfields. Progress in Neuro-Psychopharmacology and Biological Psychiatry 101, pages 109897.
Crossref
Crossref
Thiago Wendt Viola, Bernardo Aguzzoli Heberle, Aline Zaparte, Breno Sanvicente-Vieira, Leonardo Mendes Wainer, Gabriel Rodrigo Fries, Consuelo Walss-Bass & Rodrigo Grassi-Oliveira. (2019) Peripheral blood microRNA levels in females with cocaine use disorder. Journal of Psychiatric Research 114, pages 48-54.
Crossref
Crossref
Justyna Klingemann, Marta Welbel, Pablo Nicaise, Stefan Priebe, Aleksandra Matanov, Victoria Bird & Jacek Moskalewicz. (2019) Assessment and Treatment of Patients with Comorbidity of Mental Health Problems and Alcohol Use Disorders: Experiences of Clinicians and Patients in the UK and Poland. Alcohol and Alcoholism 54:3, pages 279-286.
Crossref
Crossref
Aleksi Mikael Markunpoika Hupli. (2018) Medical Cannabis for Adult Attention Deficit Hyperactivity Disorder: Sociological Patient Case Report of Cannabinoid Therapeutics in Finland. Medical Cannabis and Cannabinoids 1:2, pages 112-118.
Crossref
Crossref
Jordan SkaliskyEmily LeicklyOladunni OluwoyeSterling M. McPhersonDebra SrebnikJohn M. RollRichard K. RiesMichael G. McDonell. (2017) Prevalence and Correlates of Cannabis Use in Outpatients with Serious Mental Illness Receiving Treatment for Alcohol Use Disorders. Cannabis and Cannabinoid Research 2:1, pages 133-138.
Crossref
Crossref
T. Tellioğlu & Z. Tellioğlu. 2017. Handbook of Cannabis and Related Pathologies. Handbook of Cannabis and Related Pathologies
869
876
.
Daniel P. Notzon, John J. Mariani, Martina Pavlicova, Andrew Glass, Amy L. Mahony, Daniel J. Brooks, John Grabowski & Frances R. Levin. (2016) Mixed‐amphetamine salts increase abstinence from marijuana in patients with co‐occurring attention‐deficit/hyperactivity disorder and cocaine dependence. The American Journal on Addictions 25:8, pages 666-672.
Crossref
Crossref
Xavier Castells, Ruth Cunill, Clara Pérez-Mañá, Xavier Vidal & Dolors Capellà. (2016) Psychostimulant drugs for cocaine dependence. Cochrane Database of Systematic Reviews 2016:9.
Crossref
Crossref
M. Marszalek-Grabska, E. Gibula-Bruzda, M. Jenda, K. Gawel & J.H. Kotlinska. (2016) Memantine improves memory impairment and depressive-like behavior induced by amphetamine withdrawal in rats. Brain Research 1642, pages 389-396.
Crossref
Crossref
Philippe Lucas, Zach Walsh, Kim Crosby, Robert Callaway, Lynne Belle‐Isle, Robert Kay, Rielle Capler & Susan Holtzman. (2015) Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors. Drug and Alcohol Review 35:3, pages 326-333.
Crossref
Crossref
Thiago Wendt Viola, Saulo Gantes Tractenberg, Luis Eduardo Wearick-Silva, Caroline Silva de Oliveira Rosa, Júlio Carlos Pezzi & Rodrigo Grassi-Oliveira. (2014) Long-term cannabis abuse and early-onset cannabis use increase the severity of cocaine withdrawal during detoxification and rehospitalization rates due to cocaine dependence. Drug and Alcohol Dependence 144, pages 153-159.
Crossref
Crossref
Constanza Daigre, Carlos Roncero, Lara Grau‐López, Nieves Martínez‐Luna, Gemma Prat, Sergi Valero, Rosa Tejedor, Josep A. Ramos‐Quiroga & Miguel Casas. (2013) Attention deficit hyperactivity disorder in cocaine‐dependent adults: A psychiatric comorbidity analysis. The American Journal on Addictions 22:5, pages 466-473.
Crossref
Crossref
A.D. Kalechstein, J.H. Yoon, J.J. Mahoney,IIIIII, T.F. Newton, L. Chang & R. De La Garza,IIII. (2012) d-Cycloserine administration does not affect neurocognition in concurrent cocaine- and nicotine-dependent volunteers. Pharmacology Biochemistry and Behavior 103:2, pages 403-407.
Crossref
Crossref
Rakesh Magon & Ulrich Müller. (2018) ADHD with comorbid substance use disorder: review of treatment. Advances in Psychiatric Treatment 18:6, pages 436-446.
Crossref
Crossref
Colleen A. Hanlon, Darin L. Dufault, Michael J. Wesley & Linda J. Porrino. (2011) Elevated gray and white matter densities in cocaine abstainers compared to current users. Psychopharmacology 218:4, pages 681-692.
Crossref
Crossref
Sheila M. Alessi, Carla Rash & Nancy M. Petry. (2011) Contingency management is efficacious and improves outcomes in cocaine patients with pretreatment marijuana use. Drug and Alcohol Dependence 118:1, pages 62-67.
Crossref
Crossref
Xavier Castells, Miguel Casas, Clara Pérez-Mañá, Carlos Roncero, Xavier Vidal & Dolors Capellà. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Yolanda Alvarez, Magí Farré, Francina Fonseca & Marta Torrens. (2010) Anticonvulsant drugs in cocaine dependence: A systematic review and meta-analysis. Journal of Substance Abuse Treatment 38:1, pages 66-73.
Crossref
Crossref
Didier Jutras-AswadM.D. M. ScM.D. M. Sc, Julie BruneauM.D. M. ScM.D. M. Sc & Yasmin L. HurdPh. D.Ph. D.. (2010) Neurobiologie de la toxicomanie : avancées récentes et nouvelles stratégies d’intervention. Drogues, santé et société 8:2, pages 27-73.
Crossref
Crossref